FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890894237> ?p ?o ?g. }

• W2890894237 endingPage "322" @default.
• W2890894237 startingPage "322" @default.
• W2890894237 abstract "The aim of this paper is to compare outcomes between high-dose-rate interstitial brachytherapy (HDR-BT) monotherapy and image-guided intensity-modulated radiotherapy (IG-IMRT) for localized prostate cancer. We examined 353 HDR-BT and 270 IG-IMRT patients. To reduce background selection bias, we used the method of inverse probability treatment weighting (IPTW) with propensity scores. The actuarial five-year biochemical failure-free survival rates were 92.9% and 96.7% (p = 0.1847; p = 0.077 in IPTW) for HDR-BT and IG-IMRT, respectively; they were 100% and 95.8% (p = 0.286) for the low-risk group, 95.6% and 92% (p = 0.42) for the intermediate-risk group, 90.4% and 84.9% (p = 0.1059; p = 0.04 in IPTW) for the high-risk group, and 87.1% and 89.2% (p = 0.3816) for the very-high-risk group. In the assessment of accumulated incidences of grade ≥ 2 toxicity (Common Terminology Criteria for Adverse Events version 4.0) at five years, HDR-BT monotherapy showed higher genitourinary toxicity (11.9%) than IG-IMRT (3.3%) (p < 0.0001). The gastrointestinal toxicity was equivalent for HDR-BT (2.3%) and IG-IMRT (5.5%) (p = 0.063). No Grade 4 or 5 toxicity was detected in either modality. HDR-BT showed higher genitourinary toxicity than IG-IMRT. HDR-BT and IG-IMRT showed equivalent outcomes in low-, intermediate-, and very-high-risk groups. For high-risk patients, HDR-BT showed potential to improve prostate-specific antigen (PSA) control rate compared to IG-IMRT." @default.
• W2890894237 created "2018-09-27" @default.
• W2890894237 creator A5009528481 @default.
• W2890894237 creator A5017958083 @default.
• W2890894237 creator A5018623906 @default.
• W2890894237 creator A5019658364 @default.
• W2890894237 creator A5022117804 @default.
• W2890894237 creator A5024708797 @default.
• W2890894237 creator A5028216611 @default.
• W2890894237 creator A5032281643 @default.
• W2890894237 creator A5051543374 @default.
• W2890894237 creator A5069176748 @default.
• W2890894237 creator A5080813480 @default.
• W2890894237 creator A5081250981 @default.
• W2890894237 creator A5083529661 @default.
• W2890894237 date "2018-09-10" @default.
• W2890894237 modified "2023-10-18" @default.
• W2890894237 title "High-Dose-Rate Brachytherapy Monotherapy versus Image-Guided Intensity-Modulated Radiotherapy with Helical Tomotherapy for Patients with Localized Prostate Cancer" @default.
• W2890894237 cites W1571792083 @default.
• W2890894237 cites W2035529696 @default.
• W2890894237 cites W2062313368 @default.
• W2890894237 cites W2067593558 @default.
• W2890894237 cites W2095549404 @default.
• W2890894237 cites W2114153668 @default.
• W2890894237 cites W2126763861 @default.
• W2890894237 cites W2126781621 @default.
• W2890894237 cites W2129993942 @default.
• W2890894237 cites W2140307920 @default.
• W2890894237 cites W2156516389 @default.
• W2890894237 cites W2163954169 @default.
• W2890894237 cites W2265756519 @default.
• W2890894237 cites W2473382228 @default.
• W2890894237 cites W2532112825 @default.
• W2890894237 cites W2534892684 @default.
• W2890894237 cites W2553678345 @default.
• W2890894237 cites W2565738574 @default.
• W2890894237 cites W2602775013 @default.
• W2890894237 cites W2772306063 @default.
• W2890894237 cites W2779548578 @default.
• W2890894237 cites W2891681664 @default.
• W2890894237 cites W2973918392 @default.
• W2890894237 doi "https://doi.org/10.3390/cancers10090322" @default.
• W2890894237 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6162691" @default.
• W2890894237 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30201941" @default.
• W2890894237 hasPublicationYear "2018" @default.
• W2890894237 type Work @default.
• W2890894237 sameAs 2890894237 @default.
• W2890894237 citedByCount "5" @default.
• W2890894237 countsByYear W28908942372018 @default.
• W2890894237 countsByYear W28908942372020 @default.
• W2890894237 countsByYear W28908942372023 @default.
• W2890894237 crossrefType "journal-article" @default.
• W2890894237 hasAuthorship W2890894237A5009528481 @default.
• W2890894237 hasAuthorship W2890894237A5017958083 @default.
• W2890894237 hasAuthorship W2890894237A5018623906 @default.
• W2890894237 hasAuthorship W2890894237A5019658364 @default.
• W2890894237 hasAuthorship W2890894237A5022117804 @default.
• W2890894237 hasAuthorship W2890894237A5024708797 @default.
• W2890894237 hasAuthorship W2890894237A5028216611 @default.
• W2890894237 hasAuthorship W2890894237A5032281643 @default.
• W2890894237 hasAuthorship W2890894237A5051543374 @default.
• W2890894237 hasAuthorship W2890894237A5069176748 @default.
• W2890894237 hasAuthorship W2890894237A5080813480 @default.
• W2890894237 hasAuthorship W2890894237A5081250981 @default.
• W2890894237 hasAuthorship W2890894237A5083529661 @default.
• W2890894237 hasBestOaLocation W28908942371 @default.
• W2890894237 hasConcept C121608353 @default.
• W2890894237 hasConcept C126322002 @default.
• W2890894237 hasConcept C126838900 @default.
• W2890894237 hasConcept C126894567 @default.
• W2890894237 hasConcept C133507102 @default.
• W2890894237 hasConcept C143998085 @default.
• W2890894237 hasConcept C197934379 @default.
• W2890894237 hasConcept C2776713427 @default.
• W2890894237 hasConcept C2777416452 @default.
• W2890894237 hasConcept C2777793932 @default.
• W2890894237 hasConcept C2780192828 @default.
• W2890894237 hasConcept C29730261 @default.
• W2890894237 hasConcept C2989005 @default.
• W2890894237 hasConcept C509974204 @default.
• W2890894237 hasConcept C71924100 @default.
• W2890894237 hasConceptScore W2890894237C121608353 @default.
• W2890894237 hasConceptScore W2890894237C126322002 @default.
• W2890894237 hasConceptScore W2890894237C126838900 @default.
• W2890894237 hasConceptScore W2890894237C126894567 @default.
• W2890894237 hasConceptScore W2890894237C133507102 @default.
• W2890894237 hasConceptScore W2890894237C143998085 @default.
• W2890894237 hasConceptScore W2890894237C197934379 @default.
• W2890894237 hasConceptScore W2890894237C2776713427 @default.
• W2890894237 hasConceptScore W2890894237C2777416452 @default.
• W2890894237 hasConceptScore W2890894237C2777793932 @default.
• W2890894237 hasConceptScore W2890894237C2780192828 @default.
• W2890894237 hasConceptScore W2890894237C29730261 @default.
• W2890894237 hasConceptScore W2890894237C2989005 @default.
• W2890894237 hasConceptScore W2890894237C509974204 @default.
• W2890894237 hasConceptScore W2890894237C71924100 @default.
• W2890894237 hasIssue "9" @default.
• W2890894237 hasLocation W28908942371 @default.

• next